WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 14'0601 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 22'3161 Child (under 5 years) mortality rate: 22

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 17'948  17'763  17'576  17'388  17'201  15'170  13'141  11'234 
Births 234  235  235  236  237  254  285  259 
Surviving infants 233  233  234  234  235  251  278  247 
Pop. less than 5 years 1'170  1'174  1'179  1'184  1'189  1'287  1'388  1'214 
Pop. less than 15 years 3'616  3'635  3'655  3'676  3'697  4'029  3'850  3'740 
Female 15-49 years 4'596  4'583  4'567  4'546  4'521  4'071  3'544  2'879 

Number of reported cases

(Click for retrospective incidence data for Chile)
Diphtheria
ChartChart
  36  253 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  1'958  3'844 
Mumps
ChartChart
  1'346  863  821  876  950  2'352 
Pertussis
ChartChart
  734  1'125  1'964  5'762  2'582  3'554  59  2'795 
Polio*
ChartChart
 
Rubella
ChartChart
  743 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  10  12  22  31 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Chile)
Vaccine year result method % card seen                                                
BCG          93  98  98  92  91  93  94  96 
DTP1          97  99  92  90  94  98 
DTP3          96  95  91  90  94  91  95  93 
DTP4          90  90 
IPV1         
HepB_BD         
HepB3          96  95  90  90  94 
Hib3          96  95  90  90  94  91 
JapEnc         
MCV1          96  97  90  90  91  97  97  94 
MCV2          89  88  78  74  77 
PCV1          97  98  92  90  83 
PCV3          90  92  79  82  55 
Pol3          96  95  90  90  93  91  95  93 
Rota1         
RotaC         
RCV1          96  97  90  90  91 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Chile)
BCG
ChartChart
  93  98  98  92  91  93  94  96 
DTP1
ChartChart
  97  99  92  90  98  98  98  97 
DTP3
ChartChart
  96  95  91  90  94  91  95  93 
HepB3
ChartChart
  97  95  90  90  94 
HepB_BD
ChartChart
 
Hib3
ChartChart
  97  95  90  90  94  91 
IPV1
ChartChart
 
MCV1
ChartChart
  96  97  90  90  91  97  97  94 
MCV2
ChartChart
  89  88  78  74  77 
PCV3
ChartChart
  90  92  79  82  54 
Pol3
ChartChart
  96  95  90  90  93  91  95  93 
RCV1
ChartChart
  96  97  90  90  91  97  97 
RotaC
ChartChart
 

Number of districts in the country 345  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 55
From 80 to 89% 18
From 50 to 79% 23
Less than 50% 3
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6, 18 months; Yes
HPV 9, 10 years; Yes
HepA 18 months; No
Influenza_Adult >= 65 years; Yes and adults with chronic diseases, health care workers, pregnant women and other risk groups
Influenza_Pediatric 6-71 months; Yes and children with chronic diseases
MMR 1, 6 years; Yes
MenACWY 1 year; Yes
OPV 2, 4, 6, 18 months; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps 65 years; Yes
Tdap 6, 13 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number 2010 2020  2010-2020      2'011     
Nº of districts with microplans that include activities to raise immunization coverage number          

System performance

Total Nº districts in country number 345    345  346  346    340 
Nº districts with DTP3 coverage >=80% number 252  246    170  238  293  293 
% of districts with DTP3 coverage >=80% From 0 to 100% 73      49  69    86 
Nº districts with measles (MCV1) coverage >=95% number 90  143    84  105  163  163 
% of districts with MCV1 coverage >=95% From 0 to 100% 26      24  30    48 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes    No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.